BIOMAT Database Logo BIOMAT Database Logo

Evaluation of second-generation drug-eluting stents. 2011

Norman E Lepor
Department of Medicine, Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

UI MeSH Term Description Entries

Related Publications

Norman E Lepor
Second-generation drug-eluting coronary stents.
May 2010, The New England journal of medicine,
Norman E Lepor
Safety and efficacy outcomes of overlapping second-generation everolimus-eluting stents versus first-generation drug-eluting stents.
October 2013, The American journal of cardiology,
Norman E Lepor
Second-generation drug-eluting stents. Moving the field forward.
June 2011, Journal of the American College of Cardiology,
Norman E Lepor
Second generation drug-eluting stents: a review of the everolimus-eluting platform.
January 2013, Clinical Medicine Insights. Cardiology,
Norman E Lepor
Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease.
November 2018, Circulation,
Norman E Lepor
Comparison of angioscopic findings among second-generation drug-eluting stents.
September 2017, Journal of cardiology,
Norman E Lepor
Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
April 2023, Journal of personalized medicine,
Norman E Lepor
Second-generation everolimus-eluting stents compared to first-generation drug-eluting stents in patients treated for multivessel disease.
December 2013, Journal of interventional cardiology,
Norman E Lepor
Second versus first generation drug eluting stents during stent overexpansion.
December 2015, European review for medical and pharmacological sciences,
Norman E Lepor
Safety and efficacy of drug-eluting stents in patients with acute myocardial infarction--from first generation to second generation of drug-eluting stents.
May 2013, Journal of cardiology,
Copied contents to your clipboard!